Fish Consumption and Omega-3 Fatty Acid Status and Determinants in Long-Term Hemodialysis

Allon Friedman, Sharon Moe, Susan Perkins, Yong Li, Bruce A. Watkins

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background: Blood levels of the anti-inflammatory and cardioprotective omega-3 eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids are determined primarily by dietary consumption. There is reason to believe that hemodialysis patients are at risk for inadequate omega-3 intake and, consequently, low blood levels. Methods: This question was tested in 75 long-term hemodialysis patients and 25 matched controls by measuring fasting, predialysis plasma and red blood cell (RBC) fatty acid levels using gas chromatography and performing a fish-consumption survey. Results: Sixty-seven percent of patients did not meet American Heart Association fish-consumption guidelines for healthy persons. Compared with controls, patients had lower plasma omega-3 levels (mean % wt: DHA, 1.33 ± 0.38 [SD] versus 1.51 ± 0.36; P = 0.0370; omega-3 index [ie, EPA plus DHA], 1.67 ± 0.49 versus 1.92 ± 0.40; P = 0.0249). RBC levels, which estimate more long-term consumption, showed mixed results (EPA, 0.29 ± 0.08 versus 0.33 ± 0.11; P = 0.0816; DHA, 4.65 ± 0.92 versus 3.16 ± 1.15; P < 0.0001; omega-3 index, 4.95 ± 0.95 versus 3.49 ± 1.22; P < 0.0001). RBC omega-3 levels in patients roughly reflected fish consumption. Independent predictors of plasma and RBC omega-3 levels at the 0.05 level of significance included age, race, sex, alcohol use, and fish servings. Conclusion: Hemodialysis patients consumed fish in quantities far below current American Heart Association recommendations and manifested suboptimal omega-3 levels given their high heart disease risk. These results identify a potentially modifiable cardiovascular risk factor.

Original languageEnglish
Pages (from-to)1064-1071
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume47
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Omega-3 Fatty Acids
Renal Dialysis
Fishes
Erythrocytes
Fatty Acids
Docosahexaenoic Acids
Gas Chromatography
Heart Diseases
Fasting
Anti-Inflammatory Agents
Alcohols
Guidelines

Keywords

  • docosahexaenoic acid
  • eicosapentaenoic acid
  • Fatty acid
  • hemodialysis (HD)
  • omega-3

ASJC Scopus subject areas

  • Nephrology

Cite this

Fish Consumption and Omega-3 Fatty Acid Status and Determinants in Long-Term Hemodialysis. / Friedman, Allon; Moe, Sharon; Perkins, Susan; Li, Yong; Watkins, Bruce A.

In: American Journal of Kidney Diseases, Vol. 47, No. 6, 06.2006, p. 1064-1071.

Research output: Contribution to journalArticle

@article{96653e8555b6405688ce7238cc6d4b33,
title = "Fish Consumption and Omega-3 Fatty Acid Status and Determinants in Long-Term Hemodialysis",
abstract = "Background: Blood levels of the anti-inflammatory and cardioprotective omega-3 eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids are determined primarily by dietary consumption. There is reason to believe that hemodialysis patients are at risk for inadequate omega-3 intake and, consequently, low blood levels. Methods: This question was tested in 75 long-term hemodialysis patients and 25 matched controls by measuring fasting, predialysis plasma and red blood cell (RBC) fatty acid levels using gas chromatography and performing a fish-consumption survey. Results: Sixty-seven percent of patients did not meet American Heart Association fish-consumption guidelines for healthy persons. Compared with controls, patients had lower plasma omega-3 levels (mean {\%} wt: DHA, 1.33 ± 0.38 [SD] versus 1.51 ± 0.36; P = 0.0370; omega-3 index [ie, EPA plus DHA], 1.67 ± 0.49 versus 1.92 ± 0.40; P = 0.0249). RBC levels, which estimate more long-term consumption, showed mixed results (EPA, 0.29 ± 0.08 versus 0.33 ± 0.11; P = 0.0816; DHA, 4.65 ± 0.92 versus 3.16 ± 1.15; P < 0.0001; omega-3 index, 4.95 ± 0.95 versus 3.49 ± 1.22; P < 0.0001). RBC omega-3 levels in patients roughly reflected fish consumption. Independent predictors of plasma and RBC omega-3 levels at the 0.05 level of significance included age, race, sex, alcohol use, and fish servings. Conclusion: Hemodialysis patients consumed fish in quantities far below current American Heart Association recommendations and manifested suboptimal omega-3 levels given their high heart disease risk. These results identify a potentially modifiable cardiovascular risk factor.",
keywords = "docosahexaenoic acid, eicosapentaenoic acid, Fatty acid, hemodialysis (HD), omega-3",
author = "Allon Friedman and Sharon Moe and Susan Perkins and Yong Li and Watkins, {Bruce A.}",
year = "2006",
month = "6",
doi = "10.1053/j.ajkd.2006.03.033",
language = "English",
volume = "47",
pages = "1064--1071",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Fish Consumption and Omega-3 Fatty Acid Status and Determinants in Long-Term Hemodialysis

AU - Friedman, Allon

AU - Moe, Sharon

AU - Perkins, Susan

AU - Li, Yong

AU - Watkins, Bruce A.

PY - 2006/6

Y1 - 2006/6

N2 - Background: Blood levels of the anti-inflammatory and cardioprotective omega-3 eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids are determined primarily by dietary consumption. There is reason to believe that hemodialysis patients are at risk for inadequate omega-3 intake and, consequently, low blood levels. Methods: This question was tested in 75 long-term hemodialysis patients and 25 matched controls by measuring fasting, predialysis plasma and red blood cell (RBC) fatty acid levels using gas chromatography and performing a fish-consumption survey. Results: Sixty-seven percent of patients did not meet American Heart Association fish-consumption guidelines for healthy persons. Compared with controls, patients had lower plasma omega-3 levels (mean % wt: DHA, 1.33 ± 0.38 [SD] versus 1.51 ± 0.36; P = 0.0370; omega-3 index [ie, EPA plus DHA], 1.67 ± 0.49 versus 1.92 ± 0.40; P = 0.0249). RBC levels, which estimate more long-term consumption, showed mixed results (EPA, 0.29 ± 0.08 versus 0.33 ± 0.11; P = 0.0816; DHA, 4.65 ± 0.92 versus 3.16 ± 1.15; P < 0.0001; omega-3 index, 4.95 ± 0.95 versus 3.49 ± 1.22; P < 0.0001). RBC omega-3 levels in patients roughly reflected fish consumption. Independent predictors of plasma and RBC omega-3 levels at the 0.05 level of significance included age, race, sex, alcohol use, and fish servings. Conclusion: Hemodialysis patients consumed fish in quantities far below current American Heart Association recommendations and manifested suboptimal omega-3 levels given their high heart disease risk. These results identify a potentially modifiable cardiovascular risk factor.

AB - Background: Blood levels of the anti-inflammatory and cardioprotective omega-3 eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids are determined primarily by dietary consumption. There is reason to believe that hemodialysis patients are at risk for inadequate omega-3 intake and, consequently, low blood levels. Methods: This question was tested in 75 long-term hemodialysis patients and 25 matched controls by measuring fasting, predialysis plasma and red blood cell (RBC) fatty acid levels using gas chromatography and performing a fish-consumption survey. Results: Sixty-seven percent of patients did not meet American Heart Association fish-consumption guidelines for healthy persons. Compared with controls, patients had lower plasma omega-3 levels (mean % wt: DHA, 1.33 ± 0.38 [SD] versus 1.51 ± 0.36; P = 0.0370; omega-3 index [ie, EPA plus DHA], 1.67 ± 0.49 versus 1.92 ± 0.40; P = 0.0249). RBC levels, which estimate more long-term consumption, showed mixed results (EPA, 0.29 ± 0.08 versus 0.33 ± 0.11; P = 0.0816; DHA, 4.65 ± 0.92 versus 3.16 ± 1.15; P < 0.0001; omega-3 index, 4.95 ± 0.95 versus 3.49 ± 1.22; P < 0.0001). RBC omega-3 levels in patients roughly reflected fish consumption. Independent predictors of plasma and RBC omega-3 levels at the 0.05 level of significance included age, race, sex, alcohol use, and fish servings. Conclusion: Hemodialysis patients consumed fish in quantities far below current American Heart Association recommendations and manifested suboptimal omega-3 levels given their high heart disease risk. These results identify a potentially modifiable cardiovascular risk factor.

KW - docosahexaenoic acid

KW - eicosapentaenoic acid

KW - Fatty acid

KW - hemodialysis (HD)

KW - omega-3

UR - http://www.scopus.com/inward/record.url?scp=33646792634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646792634&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2006.03.033

DO - 10.1053/j.ajkd.2006.03.033

M3 - Article

C2 - 16731302

AN - SCOPUS:33646792634

VL - 47

SP - 1064

EP - 1071

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -